Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils: Evidence for different arachidonate pools

European Journal of Biochemistry

Volumn 269, Issue 15, 2002, Pages 3760-3770

  Fonteh, Alfred N ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Arachidonic acid; Inhibitor; Lipid mediators; Neutrophils; Phospholipase A2

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; IONOPHORE; KETONE DERIVATIVE; LEUKOTRIENE B4; LIPID; PHOSPHOLIPASE A2 INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

AMINO ACID METABOLISM; ARTICLE; BIOSYNTHESIS; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; NEUTROPHIL; PRIORITY JOURNAL;

ACYLTRANSFERASES; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CALCIMYCIN; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; IONOPHORES; LEUKOTRIENE B4; LEUKOTRIENES; LIPID METABOLISM; NEUTROPHILS; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR;

EID: 0036364888     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.03070.x     Document Type: Article

References (74)

1. 2
2. 2
3. 2
4. 2
5. 2
6. 2 gene family in mammals
7. 2
8. 2
9. 2
10. 2s preferentially expressed in type 2 helper T cells
11. 2 is coupled to hormonally regulated release of arachidonic acid
12. 2 from clonal insulin-secreting HIT cells and rat pancreatic islets: A possible molecular component of the beta-cell fuel sensor
13. 2
14. 2 from a macrophage cell line, RAW 264.7
15. 2 hydrolyzing arachidonoyl-phospholipids in mouse peritoneal macrophages
16. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells
17. 2 that mediates prostaglandin production in mast cells
18. 2 enzymes
19. 2 in eicosanoid generation
20. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells
21. 2 by P388D1 cells
22. 2
23. 2 inhibit release of free arachidonate in thrombin- stimulated human platelets
24. 2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex
25. 2 enzymes: Selective inhibitors and their pharmacological potential
26. 3, inhibits glucose-induced insulin secretion from isolated rat islets
27. 2 inhibitors from marine organisms
28. 2, blocks production of arachidonate and 12- hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets
29. 2 inhibitors. Possible new anti-inflammatory agents
30. 3, stimulates steroid secretion by dispersed human and rat adrenocortical cells
31. 2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation
32. 2 as a downstream mediator of Rac in the signaling pathway to JNK stimulation
33. Inhibitors of arachidonoyl ethanolamide hydrolysis
34. 2 by bromoenol lactone and trifluoromethyl ketones
35. Rapid remodeling of arachidonate from phosphatidylcholine to phosphatidylethanolamine pools during mast cell activation
36. Mobilization of arachidonic acid between diacyl and ether phospholipids in rabbit alveolar macrophages
37. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil
38. Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis
39. Phospholipid fatty acid remodeling in mammalian cells
40. 2 levels in murine mast cells by recombinant stem cell factor
41. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells
42. Control of arachidonate levels within inflammatory cells
43. Triacsin C: A differential inhibitor of arachidonoyl-CoA synthetase and non-specific long chain acyl-CoA synthetase
44. Fatty acid structural requirements for activity of arachidonoyl-CoA synthetase
45. 2 activities in non-pregnant and pregnant guinea-pig uterine tissues
46. Characterization of an arachidonic acid-selective acyl-CoA synthetase from murine T lymphocytes
47. CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero- 3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes
48. Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions
49. ATP-independent fatty acyl-coenzyme A synthesis from phospholipid: Coenzyme A-dependent transacylation activity toward lysophosphatidic acid catalyzed by acyl-coenzyme A. Lysophosphatidic acid acyltransferase
50. The enzymic incorporation of arachidonic acid into ether-containing choline and ethanolamine phosphoglycerides by deacylation-acylation reactions
51. Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells
52. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells
53. A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis
54. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway
55. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction
56. The CoA-independent transacylase in PAF biosynthesis: Tissue distribution and molecular species selectivity
57. 3H]arachidonic acid into molecular species of phospholipid classes by cultured human endothelial cells
58. Mobilization of different arachidonate pools and their roles in the generation of leukotrienes and free arachidonic acid during immunologic activation of mast cells
59. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils
60. Chemiluminescence of human neutrophils induced by soluble stimuli: Effect of divalent cations
61. A rapid method of total lipid extraction and purification
62. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans
63. Assessment of arachidonic acid distribution into phospholipids of inflammatory cells
64. 2 formation in rat mesangial cells
65. 2 in human platelets
66. 2 activity is not accompanied by arachidonic acid liberation in U46619-stimulated rabbit platelets
67. 2
68. 2 activity
69. CoA-independent transacylase activity is increased in human neutrophils after treatment with tumor necrosis factor alpha
70. 1-O-Alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes
71. 4 release
72. Relationship between arachidonate - Phospholipid remodeling and apoptosis
73. Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells
74. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators